Continuous hyperthermic peritoneal perfusion for peritoneal carcinomatosis.

Y. C. Chung, M. T. Huang, C. N. Chang, T. W. Huang

研究成果: 雜誌貢獻文章同行評審

4 引文 斯高帕斯(Scopus)


Continuous hyperthermic peritoneal perfusion (CHPP) with anticancer agents in warm saline was performed in 10 patients with cancer of the digestive tract and peritoneal carcinomatosis after resection of primary and metastatic lesions or both. Eight patients had colorectal cancer and one patient had recurring gastric cancer. CHPP was performed using saline containing mitomycin-C and 5-flurouracil at 42 degrees C to 43 degrees C for 60 minutes. One patient with pancreatic cancer received CHPP twice. After CHPP, the preoperative ascites of three patients disappeared. Four patients died of malignancy within 1 year of CHPP and one patient died of respiratory failure 5 months post-CHPP. The remaining five patients survived for more than 1 year after CHPP. There were no significant immediate postoperative complications, except for transient changes in liver function, white blood cell count and serum albumin level. While CHPP treatment appears to be a safe method of treatment for peritoneal carcinomatosis, its long term benefits need further investigation.

頁(從 - 到)138-143
期刊Journal of the Formosan Medical Association = Taiwan yi zhi
出版狀態已發佈 - 2月 1996

ASJC Scopus subject areas

  • 醫藥 (全部)


深入研究「Continuous hyperthermic peritoneal perfusion for peritoneal carcinomatosis.」主題。共同形成了獨特的指紋。